TY - JOUR AU - Jemal, A. AU - Siegel, R. AU - Ward, E. AU - Hao, Y. AU - Xu, J. AU - Murray, T. AU - Thun, M. J. PY - 2008 DA - 2008// TI - Cancer statistics, 2008 JO - CA Cancer J Clin VL - 58 UR - https://doi.org/10.3322/CA.2007.0010 DO - 10.3322/CA.2007.0010 ID - Jemal2008 ER - TY - JOUR AU - Petrylak, D. P. AU - Tangen, C. M. AU - Hussain, M. H. AU - Lara, P. N. AU - Jones, J. A. AU - Taplin, M. E. AU - Burch, P. A. AU - Berry, D. AU - Moinpour, C. AU - Kohli, M. PY - 2004 DA - 2004// TI - Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa041318 DO - 10.1056/NEJMoa041318 ID - Petrylak2004 ER - TY - JOUR AU - McDonnell, T. J. AU - Troncoso, P. AU - Brisbay, S. M. AU - Logothetis, C. AU - Chung, L. W. AU - Hsieh, J. T. AU - Tu, S. M. AU - Campbell, M. L. PY - 1992 DA - 1992// TI - Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer JO - Cancer Res VL - 52 ID - McDonnell1992 ER - TY - JOUR AU - Banerjee, P. P. AU - Banerjee, S. AU - Brown, T. R. PY - 2002 DA - 2002// TI - Bcl-2 protein expression correlates with cell survival and androgen independence in rat prostatic lobes JO - Endocrinology VL - 143 UR - https://doi.org/10.1210/endo.143.5.8763 DO - 10.1210/endo.143.5.8763 ID - Banerjee2002 ER - TY - JOUR AU - DiPaola, R. S. AU - Rafi, M. M. AU - Vyas, V. AU - Toppmeyer, D. AU - Rubin, E. AU - Patel, J. AU - Goodin, S. AU - Medina, M. AU - Medina, P. AU - Zamek, R. PY - 1999 DA - 1999// TI - Phase I clinical and pharmacologic study of 13-cis-retinoic acid, interferon alfa, and paclitaxel in patients with prostate cancer and other advanced malignancies JO - J Clin Oncol VL - 17 ID - DiPaola1999 ER - TY - JOUR AU - DiPaola, R. S. AU - Patel, J. AU - Rafi, M. M. PY - 2001 DA - 2001// TI - Targeting apoptosis in prostate cancer JO - Hematol Oncol Clin North Am VL - 15 UR - https://doi.org/10.1016/S0889-8588(05)70229-X DO - 10.1016/S0889-8588(05)70229-X ID - DiPaola2001 ER - TY - JOUR AU - Thalasila, A. AU - Poplin, E. AU - Shih, J. AU - Dvorzhinski, D. AU - Capanna, T. AU - Doyle-Lindrud, S. AU - Beers, S. AU - Goodin, S. AU - Rubin, E. AU - DiPaola, R. S. PY - 2003 DA - 2003// TI - A phase I trial of weekly paclitaxel, 13- cis-retinoic acid, and interferon alpha in patients with prostate cancer and other advanced malignancies JO - Cancer Chemother Pharmacol VL - 52 UR - https://doi.org/10.1007/s00280-003-0644-6 DO - 10.1007/s00280-003-0644-6 ID - Thalasila2003 ER - TY - JOUR AU - Bray, K. AU - Chen, H. Y. AU - Karp, C. M. AU - May, M. AU - Ganesan, S. AU - Karantza-Wadsworth, V. AU - DiPaola, R. S. AU - White, E. PY - 2009 DA - 2009// TI - Bcl-2 modulation to activate apoptosis in prostate cancer JO - Mol Cancer Res VL - 7 UR - https://doi.org/10.1158/1541-7786.MCR-09-0166 DO - 10.1158/1541-7786.MCR-09-0166 ID - Bray2009 ER - TY - JOUR AU - Loberg, R. D. AU - McGregor, N. AU - Ying, C. AU - Sargent, E. AU - Pienta, K. J. PY - 2007 DA - 2007// TI - In vivo evaluation of AT-101 (R-(-)-gossypol acetic acid) in androgen-independent growth of VCaP prostate cancer cells in combination with surgical castration JO - Neoplasia VL - 9 UR - https://doi.org/10.1593/neo.07778 DO - 10.1593/neo.07778 ID - Loberg2007 ER - TY - JOUR AU - Song, J. H. AU - Kandasamy, K. AU - Kraft, A. S. PY - 2008 DA - 2008// TI - ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis JO - J Biol Chem VL - 283 UR - https://doi.org/10.1074/jbc.M802511200 DO - 10.1074/jbc.M802511200 ID - Song2008 ER - TY - JOUR AU - Goodin, S. AU - Rao, K. V. AU - Kane, M. AU - Dave, N. AU - Capanna, T. AU - Doyle-Lindrud, S. AU - Engle, E. AU - Jin, L. AU - Todd, M. AU - DiPaola, R. S. PY - 2005 DA - 2005// TI - A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer JO - Cancer Chemother Pharmacol VL - 56 UR - https://doi.org/10.1007/s00280-004-0980-1 DO - 10.1007/s00280-004-0980-1 ID - Goodin2005 ER - TY - JOUR AU - Hussain, A. AU - Dipaola, R. S. AU - Baron, A. D. AU - Higano, C. S. AU - Tchekmedyian, N. S. AU - Johri, A. R. PY - 2009 DA - 2009// TI - Phase II trial of weekly patupilone in patients with castration-resistant prostate cancer JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn665 DO - 10.1093/annonc/mdn665 ID - Hussain2009 ER - TY - JOUR AU - Nakabayashi, M. AU - Ling, J. AU - Xie, W. AU - Regan, M. M. AU - Oh, W. K. PY - 2007 DA - 2007// TI - Response to vinorelbine with or without estramustine as second-line chemotherapy in patients with hormone-refractory prostate cancer JO - Cancer J VL - 13 UR - https://doi.org/10.1097/PPO.0b013e3180465940 DO - 10.1097/PPO.0b013e3180465940 ID - Nakabayashi2007 ER - TY - JOUR AU - Samelis, G. F. AU - Kalofonos, H. AU - Adamou, A. AU - Kosmides, P. AU - Skarlos, D. AU - Aravantinos, G. AU - Kiamouris, C. AU - Adimchi, O. AU - Fountzilas, G. AU - Dimopoulos, A. M. PY - 2005 DA - 2005// TI - The combination of estramustine, vinorelbine, and mitoxantrone in hormone-refractory prostate cancer: a Phase II feasibility study conducted by the Hellenic Cooperative Oncology Group JO - Urology VL - 66 UR - https://doi.org/10.1016/j.urology.2005.02.023 DO - 10.1016/j.urology.2005.02.023 ID - Samelis2005 ER - TY - JOUR AU - Patrick-Miller, L. J. PY - 2003 DA - 2003// TI - Is there a role for the assessment of health-related quality of life in the clinical evaluation of novel cytostatic agents?: Commentary re: P. M. LoRusso, Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors. Clin. Cancer Res., 9: 2040-2048, 2003 JO - Clin Cancer Res VL - 9 ID - Patrick-Miller2003 ER - TY - JOUR AU - Jaeschke, R. AU - Singer, J. AU - Guyatt, G. H. PY - 1989 DA - 1989// TI - Measurement of health status. Ascertaining the minimal clinically important difference JO - Control Clin Trials VL - 10 UR - https://doi.org/10.1016/0197-2456(89)90005-6 DO - 10.1016/0197-2456(89)90005-6 ID - Jaeschke1989 ER -